The/DT
DNA/NN
and/CC
steroid/NN
binding/NN
domains/NNS
of/IN
the/DT
glucocorticoid/NN
receptor/NN
are/VBP
not/RB
altered/VBN
in/IN
mononuclear/JJ
cells/NNS
of/IN
treated/VBN
CLL/NN
patients/NNS
./.

The/DT
aim/NN
of/IN
this/DT
study/NN
was/VBD
to/TO
investigate/VB
whether/IN
mutations/NNS
in/IN
the/DT
glucocorticoid/NN
receptor/NN
could/MD
account/VB
for/IN
the/DT
increasing/VBG
unresponsiveness/NN
of/IN
patients/NNS
with/IN
chronic/JJ
lymphatic/JJ
leukemia/NN
(/(
CLL/NN
)/)
to/TO
combination/NN
chemotherapy/NN
./.
=====
The/DT
receptor/NN
was/VBD
tested/VBN
immunocytochemically/RB
,/,
in/IN
steroid/NN
binding/NN
assays/NNS
,/,
and/CC
by/IN
a/DT
mutation/NN
screening/NN
(/(
denaturing/VBG
gradient/NN
gel/NN
electrophoresis/NN
)/)
of/IN
the/DT
receptor-cDNA/NN
./.
=====
The/DT
receptor/NN
concentration/NN
,/,
as/IN
measured/VBN
by/IN
staining/VBG
and/CC
steroid/NN
binding/NN
test/NN
,/,
varied/VBD
considerably/RB
but/CC
showed/VBD
no/DT
clear/JJ
correlation/NN
to/TO
clinical/JJ
response/NN
./.
=====
Using/VBG
a/DT
highly/RB
sensitive/JJ
mutation/NN
screening/NN
assay/NN
of/IN
the/DT
DNA-/NN
and/CC
the/DT
steroid-binding/JJ
region/NN
,/,
none/NN
of/IN
the/DT
treated/VBN
patients/NNS
revealed/VBD
any/DT
mutation/NN
,/,
suggesting/VBG
that/IN
the/DT
glucocorticoid/NN
receptor/NN
in/IN
the/DT
CLL/NN
patients/NNS
tested/VBN
is/VBZ
not/RB
altered/VBN
in/IN
these/DT
domains/NNS
./.
=====
In/IN
one/CD
individual/NN
who/WP
had/VBD
not/RB
been/VBN
treated/VBN
before/IN
analysis/NN
a/DT
silent/JJ
mutation/NN
was/VBD
found/VBN
in/IN
one/CD
receptor/NN
allele/NN
./.
=====
The/DT
results/NNS
suggest/VBP
that/IN
mechanisms/NNS
other/JJ
than/IN
altered/JJ
ligand/NN
or/CC
DNA/NN
binding/NN
of/IN
the/DT
receptor/NN
may/MD
be/VB
responsible/JJ
for/IN
the/DT
lack/NN
of/IN
response/NN
to/TO
chemotherapy/NN
./.
=====
This/DT
conclusion/NN
is/VBZ
discussed/VBN
in/IN
relation/NN
to/TO
the/DT
mechanism/NN
of/IN
corticoid/NN
resistance/NN
in/IN
mouse/NN
and/CC
human/JJ
lymphoma/NN
cells/NNS
in/IN
culture/NN
./.